Neuland Laboratories Limited (NEULANDLAB) Share Analysis
NSE · Healthcare · Pharmaceuticals
Neuland Laboratories Limited (NSE: NEULANDLAB) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100. As of 21 Sep 2026, the share price was ₹22,840.00, market capitalisation ₹29,303 Cr, P/E 58.9, ROE 21.2%.
Get the AI verdict on NEULANDLAB: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
NEULANDLAB price and valuation
- Share price
- ₹22,840.00
- Market cap
- ₹29,303 Cr
- P/E ratio
- 58.9
- P/B ratio
- 15.63
- EPS
- ₹387.97
- Book value per share
- ₹1,461.00
- Dividend yield
- 0.15%
NEULANDLAB profitability and growth
- ROE
- 21.2%
- ROCE
- 26.5%
- Debt to equity
- 0.16
- Revenue growth (3 yr)
- 19%
- Revenue growth (5 yr)
- 17%
- Profit growth (3 yr)
- 30%
- Profit growth (5 yr)
- 39%
NEULANDLAB 52-week range
- 52-week high
- ₹24,225.00
- 52-week low
- ₹11,500.00
- Face value
- ₹10.00
NEULANDLAB shareholding pattern
- Promoters
- 32.62%
- FIIs
- 21.08%
- DIIs
- 16.52%
- Public
- 29.79%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.